Find your next paid study

Augusta UniversityNCT06907992

Actual pay is set by the research site.

Phase 1Recurrent MelanomaRefractory Melanoma

Phase 1 Dose Escalation and Expansion Study of PRAME T Cell Receptor (TCR) Engineered NK Cells in Participants With Recurrent and/or Refractory Melanoma (PRAMETIME-Mel)

To find the highest tolerable dose and recommended dose of PRAME-TCR-NK cells that can be given to participants with recurrent and/or refractory melanoma. The …

M.D. Anderson Cancer CenterNCT06660420

~$150 – $3,000

Actual pay is set by the research site.

Brain Health in Breast Cancer Survivors: Interaction of Menopause and Endocrine Therapy

Endocrine therapy (ET) is widely used to treat hormone receptor positive breast cancer and prevent recurrence by downregulating estrogen function. However, ETs…

Cognitive ImpairmentCognitive Function

Jonsson Comprehensive Cancer CenterNCT04297020

Actual pay is set by the research site.

Phase 2

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of VERVE-102, a One-Time Dose Gene Editing Medicine, in Adults With or at High Risk for Atherosclerotic Cardiovascular Disease (ASCVD) Who Require Additional Low-Density Lipoprotein-Cholesterol (LDL-C) Lowering

The purpose of this study is to measure the change in bad cholesterol (LDL-C) with VERVE-102 compared to placebo in adults who have plaque buildup in their art…

AtherosclerosisCardiovascular DiseaseHypercholesterolemia

Verve Therapeutics, Inc.NCT07839936

~$75 – $2,800

Actual pay is set by the research site.

Observational

MRI-targeted Fusion or Cognitive Ultrasound-guided Biopsy to Detect Prostate Cancer

The MRI-targeted biopsy for prostate cancer detection can be performed using one of two techniques: 1. Software-based fusion of MRI and ultrasound images (sof…

Prostate CancerDiagnosis

Albany Medical CollegeNCT06517901

Actual pay is set by the research site.

LXR as a Novel Therapeutic Target in DR

Results from large clinical trials demonstrate a strong association between lipid abnormalities and progression of the most common microvascular complication, …

Diabetic Retinopathy

Pay not disclosed — ask the coordinator

University of Alabama at BirminghamNCT03403686

Observational

Exercise Training for Managing Major Depressive Disorder in Multiple Sclerosis

The purpose of this research is to examine the effects of two different exercise training regimens for managing depression and improving other health indicator…

Multiple SclerosisMajor Depressive Disorder

University of Illinois at ChicagoNCT05051618

Actual pay is set by the research site.

Acute Myeloid LeukemiaMyelodysplastic SyndromesMyeloproliferative Neoplasm+1 more

A Phase 1 Trial of CIML NK Cell Infusion for Myeloid Disease Relapse After Hematopoietic Cell Transplantation

This research study is studying cytokine induced memory-like natural killer (CIML NK) cells combined with IL-2 in adult patients (18 years of age or older) wit…

Dana-Farber Cancer InstituteNCT04024761

~$150 – $4,500

Actual pay is set by the research site.

Phase 1 Trial of ABY-029 Fluorescence in Patients With High-Grade Glioma

The purposes of the research trial are to study the safety of ABY-029 and to understand how much of the drug is needed to reach brain tumors so it can be visua…

Intracranial Tumor

Dartmouth-Hitchcock Medical CenterNCT07063693

~$150 – $3,000

Actual pay is set by the research site.

Phase 2

A Phase 2 Trial of Leflunomide, Pomalidomide, and Dexamethasone for Relapsed/Refractory Multiple Myeloma

This phase II trial studies how well leflunomide, pomalidomide, and dexamethasone work for the treatment of multiple myeloma that has come back (relapsed) or d…

Recurrent Plasma Cell MyelomaRefractory Plasma Cell Myeloma

City of Hope Medical CenterNCT04508790

~$75 – $2,000

Actual pay is set by the research site.

Observational

Continuous Glucose Monitoring for Outpatient Diabetes Management After Hospital Discharge

This study aims to improve patient awareness of the utility of continuous glucose monitoring systems in blood glucose monitoring and to improve patient satisfa…

Type 2 Diabetes Mellitus (T2DM)Type 1 Diabetes Mellitus (T1DM)Hyperglycemia

Vanderbilt University Medical CenterNCT06852950

Actual pay is set by the research site.

Phase 1/2A Study of OTP-01, a Dual Paratopic PD-1/VEGFR2 Antibody, in Patients With Advanced Solid Tumors

The main goals of this clinical trial are to find out what the best dose of the study drug, OTP-01, is for patients with solid tumors through understanding how…

Advanced Solid Tumors